MFDS — authorised 24 December 1987
- Marketing authorisation holder: MEDA PHARMS
- Status: likely_approved
🇰🇷 Rowasa in South Korea
MFDS authorised Rowasa on 24 December 1987
Marketing authorisation
Rowasa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Rowasa approved in South Korea?
Yes. MFDS authorised it on 24 December 1987.
Who is the marketing authorisation holder for Rowasa in South Korea?
MEDA PHARMS holds the South Korean marketing authorisation.